Evaluation of the HekaHeart Platform in Medication Management for Heart Failure Patients

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DEVICE

HekaHeart platform medication management and remote monitoring

Onboarding to the HekaHeart platform which includes a personalized GDMT management plan along with remote monitoring kits including a scale, blood pressure cuff, and heart rate monitor. Patients engage in video and phone calls with clinicians who will use established standardized clinical protocols to guide medication and vital optimization. Once patients are determined to be maximally titrated on all GDMT, they are transitioned back to standard clinical care.

Trial Locations (2)

06437

Shoreline Medical Center- 111 Goose Lane location, Guilford

06519

Yale Physicians Building- 800 Howard Ave location, New Haven

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

HekaHeart

UNKNOWN

lead

Yale University

OTHER